| Brian R Fradette, DPM | |
|
6 Tsienneto Rd, Suite 303, Derry, NH 03038-1584 | |
| (603) 432-2508 | |
| (603) 432-2008 |
| Full Name | Brian R Fradette |
|---|---|
| Gender | Male |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 6 Tsienneto Rd, Derry, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679594592 | NPI | - | NPPES |
| 80488249 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | NH0149 (New Hampshire) | Primary |
| Provider Name | Foot & Ankle Associates Of Southern Nh, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1558824631 PECOS PAC ID: 6608209085 Enrollment ID: O20191126001943 |
News Archive
In response to concern over gadolinium-based contrast agents, Little Company of Mary, a not-for-profit Catholic community hospital in Evergreen Park, Ill., wanted to provide the highest quality and safest MRA procedures to its patients. To accomplish this, the facility installed Toshiba America Medical Systems, Inc.'s Vantage Atlas® MR system and utilized the full suite of proprietary contrast-free MRA techniques.
Clinical trial results from Array BioPharma's wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib, were presented this weekend at the European Society of Medical Oncology's annual European Cancer Conference (ECC). At the meeting, preliminary data were shared from both a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2) and a Phase 1b/2 combination trial of binimetinib and ribociclib (Novartis, LEE011), a CDK4/6 inhibitor in NRAS-mutant melanoma patients.
The Intellectual Property and Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, recently honored Genentech Partnering and Seragon, and Regeneron and Avalanche with the Allicense 2015 Breakthrough Award for Deals of the Year.
Visitors attending the Minnesota State Fair will find some great health deals when they stop by Health Fair 11 at the Fair. More than a dozen organizations will offer free or low-cost health screenings. Among the screenings are: cholesterol testing (non-fasting), diabetes screening (glucose - non-fasting), blood pressure checks, blood typing, hearing and vision assessments, bone density and body fat measurements, and weight readings.
A new study by a team of cardiologists at Beth Israel Deaconess Medical Center led by senior and corresponding author Jeffrey Popma, MD, suggests that a minimally invasive procedure currently reserved for patients too frail to undergo surgery may in fact be a safe and effective alternative for healthier patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian R Fradette, DPM 6 Tsienneto Rd, Suite 303, Derry, NH 03038-1584 Ph: (603) 432-2508 | Brian R Fradette, DPM 6 Tsienneto Rd, Suite 303, Derry, NH 03038-1584 Ph: (603) 432-2508 |
News Archive
In response to concern over gadolinium-based contrast agents, Little Company of Mary, a not-for-profit Catholic community hospital in Evergreen Park, Ill., wanted to provide the highest quality and safest MRA procedures to its patients. To accomplish this, the facility installed Toshiba America Medical Systems, Inc.'s Vantage Atlas® MR system and utilized the full suite of proprietary contrast-free MRA techniques.
Clinical trial results from Array BioPharma's wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib, were presented this weekend at the European Society of Medical Oncology's annual European Cancer Conference (ECC). At the meeting, preliminary data were shared from both a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2) and a Phase 1b/2 combination trial of binimetinib and ribociclib (Novartis, LEE011), a CDK4/6 inhibitor in NRAS-mutant melanoma patients.
The Intellectual Property and Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, recently honored Genentech Partnering and Seragon, and Regeneron and Avalanche with the Allicense 2015 Breakthrough Award for Deals of the Year.
Visitors attending the Minnesota State Fair will find some great health deals when they stop by Health Fair 11 at the Fair. More than a dozen organizations will offer free or low-cost health screenings. Among the screenings are: cholesterol testing (non-fasting), diabetes screening (glucose - non-fasting), blood pressure checks, blood typing, hearing and vision assessments, bone density and body fat measurements, and weight readings.
A new study by a team of cardiologists at Beth Israel Deaconess Medical Center led by senior and corresponding author Jeffrey Popma, MD, suggests that a minimally invasive procedure currently reserved for patients too frail to undergo surgery may in fact be a safe and effective alternative for healthier patients.
› Verified 7 days ago
Brian D Tedesco, Dpm & George A Abboud Dpm Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 44 Birch St Ste 301, Derry, NH 03038 Phone: 603-260-6554 Fax: 603-260-6559 | |
Dr. William Harold Simons, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4 Birch St, Derry, NH 03038 Phone: 606-434-1421 Fax: 603-434-0309 | |
Foot & Ankle Associates Of Southern Nh, Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 6 Tsienneto Rd Ste 303, Derry, NH 03038 Phone: 603-432-2508 | |
Dr. Victor Joseph Quijano Jr., DPM, PHD Podiatrist Medicare: Medicare Enrolled Practice Location: 6 Tsienneto Rd, Suite 303, Derry, NH 03038 Phone: 603-432-2508 Fax: 603-432-2008 | |
Brian Fradette Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 6 Tsienneto Rd, Suite 303, Derry, NH 03038 Phone: 603-432-2508 |